Grady Health System has proved that intensive glycemic control, rather than conservative control, is safe and better for patients.
Clinical and financial impact of inpatient diabetes care and glycemic management in the ICU and Non-ICU. Dr. Guillermo Umpierrez of Emory University and Grady Health. TOPICTIME STAMPIntroducing Dr. Guiellermo Umpierrez00:00 Diabetes Research at Emory University01:18 Hypoglycemia in the ICU03:24 Clinical Inertia Surrounding Glycemic Control05:14 Current Glycemic Guidelines and Targets06:06 Reducing Complications for Cardiovascular Surgery Patients07:10 Reducing ICU Stay for Cardiovascular …
What do hospital executives say about using Glytec’s eGMS to combat the cost, quality and safety issues surrounding hypoglycemia?
Improvements in quality and safety of patient care through changes to insulin management protocols, including the transition from Monarch Medical Technologies’ EndoTool to Glytec’s Glucommander. MedPage Today interviews Dr. Valerie Garrett.
Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, operations perspective. Audrey Douglas-Cooke, Vice President Operations and Associate Nursing Executive.
A new standard of care for glycemic control: Sentara Healthcare’s transition to Glytec’s eGMS, executive perspective. Dr. Paul Chidester, Vice President Medical Affairs, and Dr. H. Courtenay Harrison, Jr., Medical Director Diabetes Center.
Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.